Cybin (Drug Discovery)
Drug Discovery
Cybin (Drug Discovery) valuation and funding history | Last updated: March 19, 2024 | 1 funding rounds
Current Valuation
N/A
As of March 19, 2024
Total Funding Raised
N/A
Across 1 round
Last Round
PIPE
$150.0M
Last Funding
Mar 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| March 19, 2024 | PIPE | $150.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Cybin (Drug Discovery) is currently valued at N/A as of March 19, 2024.
Explore More Data
Detailed analysis for Cybin (Drug Discovery)
What is Cybin (Drug Discovery) Worth in 2026?
Cybin (Drug Discovery) is a leading private company in the Drug Discovery sector. Track Cybin (Drug Discovery)'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Cybin (Drug Discovery) Valuation is Determined
Private company valuations like Cybin (Drug Discovery)'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.